IPHA
Price
$1.90
Change
-$0.09 (-4.55%)
Updated
Jun 13 closing price
Capitalization
180.65M
NAUT
Price
$0.70
Change
-$0.01 (-1.41%)
Updated
Jun 13 closing price
Capitalization
88.43M
50 days until earnings call
Interact to see
Advertisement

IPHA vs NAUT

Header iconIPHA vs NAUT Comparison
Open Charts IPHA vs NAUTBanner chart's image
Innate Pharma SA
Price$1.90
Change-$0.09 (-4.55%)
Volume$12.58K
Capitalization180.65M
Nautilus Biotechnolgy
Price$0.70
Change-$0.01 (-1.41%)
Volume$160.56K
Capitalization88.43M
IPHA vs NAUT Comparison Chart
Loading...
IPHA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NAUT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IPHA vs. NAUT commentary
Jun 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IPHA is a StrongBuy and NAUT is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 16, 2025
Stock price -- (IPHA: $1.89 vs. NAUT: $0.70)
Brand notoriety: IPHA and NAUT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IPHA: 65% vs. NAUT: 89%
Market capitalization -- IPHA: $180.65M vs. NAUT: $88.43M
IPHA [@Biotechnology] is valued at $180.65M. NAUT’s [@Biotechnology] market capitalization is $88.43M. The market cap for tickers in the [@Biotechnology] industry ranges from $356.66B to $0. The average market capitalization across the [@Biotechnology] industry is $2.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IPHA’s FA Score shows that 1 FA rating(s) are green whileNAUT’s FA Score has 1 green FA rating(s).

  • IPHA’s FA Score: 1 green, 4 red.
  • NAUT’s FA Score: 1 green, 4 red.
According to our system of comparison, both IPHA and NAUT are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IPHA’s TA Score shows that 4 TA indicator(s) are bullish while NAUT’s TA Score has 1 bullish TA indicator(s).

  • IPHA’s TA Score: 4 bullish, 6 bearish.
  • NAUT’s TA Score: 1 bullish, 8 bearish.
According to our system of comparison, IPHA is a better buy in the short-term than NAUT.

Price Growth

IPHA (@Biotechnology) experienced а -12.67% price change this week, while NAUT (@Biotechnology) price change was -8.84% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.63%. For the same industry, the average monthly price growth was +13.05%, and the average quarterly price growth was +4.06%.

Reported Earning Dates

NAUT is expected to report earnings on Aug 05, 2025.

Industries' Descriptions

@Biotechnology (-0.63% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IPHA($181M) has a higher market cap than NAUT($88.4M). IPHA YTD gains are higher at: 2.989 vs. NAUT (-58.274).
IPHANAUTIPHA / NAUT
Capitalization181M88.4M205%
EBITDAN/A-72.33M-
Gain YTD2.989-58.274-5%
P/E RatioN/AN/A-
RevenueN/A0-
Total CashN/A139M-
Total DebtN/A29.3M-
FUNDAMENTALS RATINGS
NAUT: Fundamental Ratings
NAUT
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
11
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
95
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IPHANAUT
RSI
ODDS (%)
Bullish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
82%
Bullish Trend 4 days ago
84%
Momentum
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
88%
MACD
ODDS (%)
Bearish Trend 4 days ago
83%
Bearish Trend 4 days ago
81%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
85%
Bearish Trend 4 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
85%
Bearish Trend 4 days ago
83%
Advances
ODDS (%)
Bullish Trend 26 days ago
73%
N/A
Declines
ODDS (%)
Bearish Trend 4 days ago
84%
Bearish Trend 4 days ago
83%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
89%
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
Bearish Trend 4 days ago
87%
Bearish Trend 5 days ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
IPHA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NAUT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GLNCY7.880.09
+1.16%
Glencore Plc
SNWGF5.77-0.03
-0.44%
SNOWLINE GOLD CORP
ASMIY597.57-10.44
-1.72%
ASM International N.V.
PEVM0.20N/A
-2.44%
Phoenix Motor Inc
ACCYY9.98-0.53
-5.07%
Accor SA Ltd.

IPHA and

Correlation & Price change

A.I.dvisor tells us that IPHA and TECH have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IPHA and TECH's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IPHA
1D Price
Change %
IPHA100%
-4.05%
TECH - IPHA
29%
Poorly correlated
-1.96%
QSI - IPHA
27%
Poorly correlated
-7.26%
ENTA - IPHA
25%
Poorly correlated
+1.21%
NAUT - IPHA
24%
Poorly correlated
-1.78%
LRMR - IPHA
24%
Poorly correlated
-1.03%
More

NAUT and

Correlation & Price change

A.I.dvisor indicates that over the last year, NAUT has been loosely correlated with FHTX. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if NAUT jumps, then FHTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NAUT
1D Price
Change %
NAUT100%
-1.78%
FHTX - NAUT
49%
Loosely correlated
-4.85%
IMNM - NAUT
45%
Loosely correlated
-6.03%
TECH - NAUT
42%
Loosely correlated
-1.96%
ELVN - NAUT
41%
Loosely correlated
+11.44%
APGE - NAUT
40%
Loosely correlated
+6.26%
More